160701-56-4Relevant articles and documents
INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
-
, (2014/10/15)
The disclosure generally relates to compounds of formula (I), including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.
INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
-
Page/Page column 75, (2014/10/15)
The disclosure generally relates to compounds of formula (I), including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.
A mild, convenient, Non-Acidic conversion of enol ethers into alcohols using Hg(OAc)2 - NaBH4
Crouch, R. David,Mitten, Jeffrey V.,Span, Amelia R.,Dai, H. George
, p. 791 - 794 (2007/10/03)
Alkyl enol ethers can be converted into the corresponding alcohols in good to excellent yields by treatment with aqueous Hg(OAc)2 - NaBH4 in one reaction flask. This method is sufficiently mild to allow the survival of acid-sensitive groups such as silyl ethers, THP-protected alcohols and N-Boc-protected amines.
